Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.18
(0.56%)
HKD 0.18
(0.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 103.4 Million HKD | 142.09% |
| 2022 | -245.69 Million HKD | -182.86% |
| 2021 | 296.53 Million HKD | 174.93% |
| 2020 | -395.75 Million HKD | 2.9% |
| 2019 | -407.56 Million HKD | -56.59% |
| 2018 | -260.27 Million HKD | -12.65% |
| 2017 | -231.04 Million HKD | -36.08% |
| 2016 | -169.78 Million HKD | 28.32% |
| 2015 | -236.86 Million HKD | 47.56% |
| 2014 | -451.68 Million HKD | 20.66% |
| 2013 | -569.3 Million HKD | -681.59% |
| 2012 | -72.83 Million HKD | 41.2% |
| 2011 | -123.88 Million HKD | -2461.01% |
| 2010 | 5.24 Million HKD | -53.41% |
| 2009 | 11.26 Million HKD | -98.49% |
| 2008 | 745.2 Million HKD | 1185.97% |
| 2007 | -68.62 Million HKD | -7.13% |
| 2006 | -64.05 Million HKD | -20.96% |
| 2005 | -52.95 Million HKD | -29.16% |
| 2004 | -40.99 Million HKD | 97.19% |
| 2003 | -1.45 Billion HKD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | 103.4 Million HKD | 142.09% |
| 2023 Q1 | 96.84 Million HKD | 174.47% |
| 2023 Q2 | 193.68 Million HKD | 100.0% |
| 2023 Q3 | -45.14 Million HKD | -123.31% |
| 2023 Q4 | -90.28 Million HKD | -100.0% |
| 2022 Q3 | -65.01 Million HKD | 43.79% |
| 2022 Q4 | -130.03 Million HKD | -100.0% |
| 2022 Q1 | -57.83 Million HKD | 27.05% |
| 2022 Q2 | -115.66 Million HKD | -100.0% |
| 2022 FY | -245.69 Million HKD | -182.86% |
| 2021 FY | 296.53 Million HKD | 174.93% |
| 2021 Q1 | 62.53 Million HKD | 156.09% |
| 2021 Q2 | 125.07 Million HKD | 100.0% |
| 2021 Q3 | -39.63 Million HKD | -131.69% |
| 2021 Q4 | -79.27 Million HKD | -100.0% |
| 2020 Q2 | -93.44 Million HKD | -100.0% |
| 2020 FY | -395.75 Million HKD | 2.9% |
| 2020 Q3 | -55.74 Million HKD | 40.35% |
| 2020 Q1 | -46.72 Million HKD | 53.57% |
| 2020 Q4 | -111.49 Million HKD | -100.0% |
| 2019 FY | -407.56 Million HKD | -56.59% |
| 2019 Q1 | -55.23 Million HKD | -24.14% |
| 2019 Q2 | -110.47 Million HKD | -100.0% |
| 2019 Q3 | -50.31 Million HKD | 54.45% |
| 2019 Q4 | -100.63 Million HKD | -100.0% |
| 2018 Q3 | -44.49 Million HKD | 48.04% |
| 2018 Q4 | -44.49 Million HKD | 0.0% |
| 2018 Q2 | -85.63 Million HKD | 0.0% |
| 2018 Q1 | -85.63 Million HKD | -102.99% |
| 2018 FY | -260.27 Million HKD | -12.65% |
| 2017 FY | -231.04 Million HKD | -36.08% |
| 2017 Q3 | -42.18 Million HKD | 42.47% |
| 2017 Q2 | -73.33 Million HKD | 0.0% |
| 2017 Q1 | -73.33 Million HKD | -51.99% |
| 2017 Q4 | -42.18 Million HKD | 0.0% |
| 2016 Q4 | -48.24 Million HKD | 0.0% |
| 2016 Q1 | -36.64 Million HKD | 50.95% |
| 2016 Q2 | -36.64 Million HKD | 0.0% |
| 2016 Q3 | -48.24 Million HKD | -31.67% |
| 2016 FY | -169.78 Million HKD | 28.32% |
| 2015 Q1 | -43.72 Million HKD | 14.84% |
| 2015 Q3 | -74.7 Million HKD | -70.84% |
| 2015 Q2 | -43.72 Million HKD | 0.0% |
| 2015 Q4 | -74.7 Million HKD | 0.0% |
| 2015 FY | -236.86 Million HKD | 47.56% |
| 2014 Q1 | -174.49 Million HKD | 0.0% |
| 2014 FY | -451.68 Million HKD | 20.66% |
| 2014 Q4 | -51.34 Million HKD | 0.0% |
| 2014 Q3 | -51.34 Million HKD | 70.57% |
| 2014 Q2 | -174.49 Million HKD | 0.0% |
| 2013 FY | -569.3 Million HKD | -681.59% |
| 2013 Q2 | -13.8 Million HKD | -32.45% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | -10.42 Million HKD | 56.49% |
| 2012 Q2 | -5.44 Million HKD | 0.0% |
| 2012 Q4 | -23.95 Million HKD | -339.81% |
| 2012 Q3 | -5.44 Million HKD | 0.0% |
| 2012 FY | -72.83 Million HKD | 41.2% |
| 2011 FY | -123.88 Million HKD | -2461.01% |
| 2010 FY | 5.24 Million HKD | -53.41% |
| 2009 FY | 11.26 Million HKD | -98.49% |
| 2008 FY | 745.2 Million HKD | 1185.97% |
| 2007 FY | -68.62 Million HKD | -7.13% |
| 2006 FY | -64.05 Million HKD | -20.96% |
| 2005 FY | -52.95 Million HKD | -29.16% |
| 2004 FY | -40.99 Million HKD | 97.19% |
| 2003 FY | -1.45 Billion HKD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | -15.11 Million HKD | 784.29% |
| China Overseas Nuoxin International Holdings Limited | -15.5 Million HKD | 766.815% |
| Prosperous Future Holdings Limited | -38.74 Million HKD | 366.86% |
| Huasheng International Holding Limited | -31.44 Million HKD | 428.879% |
| Fourace Industries Group Holdings Limited | 38.71 Million HKD | -167.081% |
| Evergreen Products Group Limited | 51.01 Million HKD | -102.707% |
| EC Healthcare | -18.94 Million HKD | 645.749% |
| Ming Fai International Holdings Limited | 104.18 Million HKD | 0.747% |
| Blue Moon Group Holdings Limited | 325.3 Million HKD | 68.214% |
| SuperRobotics Holdings Limited | -27.75 Million HKD | 472.543% |
| Takbo Group Holdings Limited | 14.65 Million HKD | -605.437% |
| Hyfusin Group Holdings Limited | 102.28 Million HKD | -1.092% |